Press Release
May 20, 2026
Eyes of AI™ Selected for Prestigious MedTech Innovator Asia Pacific 2026 Accelerator Cohort
One of 20 startups selected from more than 680 applicants, representing the top 3% of this year's applicant pool.
Selected to join the eighth annual APAC Accelerator Program by the world's largest accelerator of medical technology companies.
Sydney, Australia – May 20, 2026 – Eyes of AI™, an Australian dental AI company pioneering integrated hardware and software solutions for AI-powered dental diagnostics, today announced its selection into the prestigious MedTech Innovator Asia Pacific 2026 APAC Accelerator Cohort.
Eyes of AI™ is one of 20 companies selected from more than 680 applicants for this year's program, representing approximately the top 3% of applicants. The cohort was selected following a regional evaluation process that included 67 startups, 112 unique judges, and four virtual and in-person pitch events across MedTech Innovator Asia Pacific 2026 Pitch Event RoadTour.
“We are honoured to join MedTech Innovator Asia Pacific 2026 APAC Accelerator Program. This opportunity gives us access to a strong network of judges, partners, investors, and healthcare leaders as we work to advance our AI-powered technologies spanning advanced imaging, intelligent software and next generation hardware innovation.”
Khoa Le, CEO, Eyes of AI™
The 2026 APAC Accelerator Program runs from June to October 2026 and includes the Innovator Summit from June 3–4 in San Francisco, the Wilson Sonsini Medical Device Conference on June 5, and the 2026 APAC Grand Finals on October 26 in Singapore.
Eyes of AI™ was selected based on its AI-powered technologies that address a critical need for faster and more accurate clinical decision support in dental and oral healthcare. The company's work across intelligent software and next-generation dental hardware strongly aligns with MedTech Innovator's mission to improve human health by accelerating companies transforming healthcare.
About Eyes of AI™
Founded in Sydney, Australia in 2020, Eyes of AI™ is a global dental AI company developing advanced artificial intelligence across 2D X-rays, 3D CBCT imaging, intraoral scans, and cephalometric analysis. The company's technologies support clinicians through AI-powered pathology detection, 3D segmentation, treatment planning, and diagnostic assistance across multiple imaging modalities.
Eyes of AI™ has expanded internationally with users across more than 100 countries and has received recognition through major industry awards, government-backed innovation programs, and strategic partnerships with leading research institutions and global dental imaging companies.
MedTech Innovator
About MedTech Innovator
MedTech Innovator is the world's largest accelerator of medical technology companies. Since its founding, the organization has reviewed more than 14,000 applications and supported 838 portfolio companies that have collectively raised more than USD 11.4 billion in follow-on funding.
Since launching in 2019, MedTech Innovator Asia Pacific has supported medtech startups across 20 countries in the region, with 154 APAC alumni collectively raising more than USD 335 million in funding.
For more information about MedTech Innovator Asia Pacific, visit www.medtechinnovator.asia, follow MedTech Innovator Asia Pacific on LinkedIn, or subscribe to the organization's newsletter.
Media Contact: Rebecca Chia, Communications and Partnerships Manager, Eyes of AI™ — rebecca.chia@eyesofai.com
Passionate about making an impact in the world of AI and Medtech? Make a difference.